Olema Pharmaceuticals (OLMA) Other Non-Current Assets (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Other Non-Current Assets data on file, last reported at $16.5 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $16.5 million, up 117721.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.5 million (up 117721.43% YoY), and the FY2025 annual result was $16.8 million, up 50.39% from the prior year.
• Other Non-Current Assets retreated to $16.5 million in Q1 2026 per OLMA's latest filing, from $16.8 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $16.8 million in Q4 2025 and troughed at $14000.0 in Q1 2025.
• A 5-year average of $6.8 million and a median of $4.3 million in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets sank 99.86% in 2025, then jumped 117721.43% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $4.3 million in 2022, then surged by 91.51% to $8.1 million in 2023, then jumped by 37.48% to $11.2 million in 2024, then surged by 50.39% to $16.8 million in 2025, then dropped by 2.0% to $16.5 million in 2026.
• Business Quant data shows OLMA's Other Non-Current Assets at $16.5 million in Q1 2026, $16.8 million in Q4 2025, and $16.7 million in Q3 2025.